Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.
- DOI
- 10.1038/s41467-021-27038-5
- Published
- 2021 Nov 18
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-021-27038-5,
title = {Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.},
author = {Ryzhakov G and Almuttaqi H and Corbin AL and Berthold DL and Khoyratty T and Eames HL and Bullers S and Pearson C and Ai Z and Zec K and Bonham S and Fischer R and Jostins-Dean L and Travis SPL and Kessler BM and Udalova IA},
year = {2021},
journal = {Nature communications},
doi = {10.1038/s41467-021-27038-5},
url = {https://doi.org/10.1038/s41467-021-27038-5}
}RIS
TY - JOUR TI - Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation. AU - Ryzhakov G AU - Almuttaqi H AU - Corbin AL AU - Berthold DL AU - Khoyratty T AU - Eames HL AU - Bullers S AU - Pearson C AU - Ai Z AU - Zec K AU - Bonham S AU - Fischer R AU - Jostins-Dean L AU - Travis SPL AU - Kessler BM AU - Udalova IA PY - 2021 JO - Nature communications DO - 10.1038/s41467-021-27038-5 UR - https://doi.org/10.1038/s41467-021-27038-5 ER -
APA
G, R., H, A., AL, C., DL, B., T, K., HL, E., S, B., C, P., Z, A., K, Z., S, B., R, F., L, J., SPL, T., BM, K., & IA, U. (2021). Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.. Nature communications. https://doi.org/10.1038/s41467-021-27038-5
Source records
- pubmed · retrieved 2026-09-27T11:59:53.686Z